{"pmid":32277235,"title":"My Future in Medicine: How COVID-19 is Inspiring the Next Generation of Infectious Disease Specialists.","text":["My Future in Medicine: How COVID-19 is Inspiring the Next Generation of Infectious Disease Specialists.","J Infect Dis","Allen, Jawara","32277235"],"journal":"J Infect Dis","authors":["Allen, Jawara"],"date":"2020-04-12T11:00:00Z","year":2020,"_id":"32277235","week":"202015|Apr 06 - Apr 12","doi":"10.1093/infdis/jiaa178","source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663798882954379264,"score":7.9164424,"similar":[{"pmid":32088333,"pmcid":"PMC7102576","title":"Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases.","text":["Lessons learned from the 2019-nCoV epidemic on prevention of future infectious diseases.","Only a month after the outbreak of pneumonia caused by 2019-nCoV, more than forty-thousand people were infected. This put enormous pressure on the Chinese government, medical healthcare provider, and the general public, but also made the international community deeply nervous. On the 25th day after the outbreak, the Chinese government implemented strict traffic restrictions on the area where the 2019-nCoV had originated-Hubei province, whose capital city is Wuhan. Ten days later, the rate of increase of cases in Hubei showed a significant difference (p = 0.0001) compared with the total rate of increase in other provinces of China. These preliminary data suggest the effectiveness of a traffic restriction policy for this pandemic thus far. At the same time, solid financial support and improved research ability, along with network communication technology, also greatly facilitated the application of epidemic prevention measures. These measures were motivated by the need to provide effective treatment of patients, and involved consultation with three major groups in policy formulation-public health experts, the government, and the general public. It was also aided by media and information technology, as well as international cooperation. This experience will provide China and other countries with valuable lessons for quickly coordinating and coping with future public health emergencies.","Microbes Infect","Pan, Xingchen","Ojcius, David M","Gao, Tianyue","Li, Zhongsheng","Pan, Chunhua","Pan, Chungen","32088333"],"abstract":["Only a month after the outbreak of pneumonia caused by 2019-nCoV, more than forty-thousand people were infected. This put enormous pressure on the Chinese government, medical healthcare provider, and the general public, but also made the international community deeply nervous. On the 25th day after the outbreak, the Chinese government implemented strict traffic restrictions on the area where the 2019-nCoV had originated-Hubei province, whose capital city is Wuhan. Ten days later, the rate of increase of cases in Hubei showed a significant difference (p = 0.0001) compared with the total rate of increase in other provinces of China. These preliminary data suggest the effectiveness of a traffic restriction policy for this pandemic thus far. At the same time, solid financial support and improved research ability, along with network communication technology, also greatly facilitated the application of epidemic prevention measures. These measures were motivated by the need to provide effective treatment of patients, and involved consultation with three major groups in policy formulation-public health experts, the government, and the general public. It was also aided by media and information technology, as well as international cooperation. This experience will provide China and other countries with valuable lessons for quickly coordinating and coping with future public health emergencies."],"journal":"Microbes Infect","authors":["Pan, Xingchen","Ojcius, David M","Gao, Tianyue","Li, Zhongsheng","Pan, Chunhua","Pan, Chungen"],"date":"2020-02-24T11:00:00Z","year":2020,"_id":"32088333","week":"20209|Feb 24 - Mar 01","doi":"10.1016/j.micinf.2020.02.004","keywords":["*2019-nCoV","*Government","*Public health emergency","*Traffic restriction"],"source":"PubMed","locations":["China","Wuhan","Chinese","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352134528139264,"score":54.063797},{"pmid":32162995,"title":"Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine.","text":["Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine.","The epidemic of coronavirus disease 2019 (COVID-19), originating in Wuhan, China, has become a major public health challenge for not only China but also countries around the world. The World Health Organization announced that the outbreaks of the novel coronavirus have constituted a public health emergency of international concern. As of February 26, 2020, COVID-19 has been recognized in 34 countries, with a total of 80,239 laboratory-confirmed cases and 2,700 deaths. Infection control measures are necessary to prevent the virus from further spreading and to help control the epidemic situation. Due to the characteristics of dental settings, the risk of cross infection can be high between patients and dental practitioners. For dental practices and hospitals in areas that are (potentially) affected with COVID-19, strict and effective infection control protocols are urgently needed. This article, based on our experience and relevant guidelines and research, introduces essential knowledge about COVID-19 and nosocomial infection in dental settings and provides recommended management protocols for dental practitioners and students in (potentially) affected areas.","J Dent Res","Meng, L","Hua, F","Bian, Z","32162995"],"abstract":["The epidemic of coronavirus disease 2019 (COVID-19), originating in Wuhan, China, has become a major public health challenge for not only China but also countries around the world. The World Health Organization announced that the outbreaks of the novel coronavirus have constituted a public health emergency of international concern. As of February 26, 2020, COVID-19 has been recognized in 34 countries, with a total of 80,239 laboratory-confirmed cases and 2,700 deaths. Infection control measures are necessary to prevent the virus from further spreading and to help control the epidemic situation. Due to the characteristics of dental settings, the risk of cross infection can be high between patients and dental practitioners. For dental practices and hospitals in areas that are (potentially) affected with COVID-19, strict and effective infection control protocols are urgently needed. This article, based on our experience and relevant guidelines and research, introduces essential knowledge about COVID-19 and nosocomial infection in dental settings and provides recommended management protocols for dental practitioners and students in (potentially) affected areas."],"journal":"J Dent Res","authors":["Meng, L","Hua, F","Bian, Z"],"date":"2020-03-13T11:00:00Z","year":2020,"_id":"32162995","week":"202011|Mar 09 - Mar 15","doi":"10.1177/0022034520914246","keywords":["dental education","dental practice management","dental public health","infection control","transmission","virology"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1663352134027968512,"score":44.93916},{"pmid":32087334,"pmcid":"PMC7079563","title":"The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.","text":["The epidemic of 2019-novel-coronavirus (2019-nCoV) pneumonia and insights for emerging infectious diseases in the future.","At the end of December 2019, a novel coronavirus, 2019-nCoV, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to the whole country of China, which has posed great threats to public health and attracted enormous attention around the world. To date, there are no clinically approved vaccines or antiviral drugs available for these human coronavirus infections. Intensive research on the novel emerging human infectious coronaviruses is urgently needed to elucidate their route of transmission and pathogenic mechanisms, and to identify potential drug targets, which would promote the development of effective preventive and therapeutic countermeasures. Herein, we describe the epidemic and etiological characteristics of 2019-nCoV, discuss its essential biological features, including tropism and receptor usage, summarize approaches for disease prevention and treatment, and speculate on the transmission route of 2019-nCoV.","Microbes Infect","Li, Jin-Yan","You, Zhi","Wang, Qiong","Zhou, Zhi-Jian","Qiu, Ye","Luo, Rui","Ge, Xing-Yi","32087334"],"abstract":["At the end of December 2019, a novel coronavirus, 2019-nCoV, caused an outbreak of pneumonia spreading from Wuhan, Hubei province, to the whole country of China, which has posed great threats to public health and attracted enormous attention around the world. To date, there are no clinically approved vaccines or antiviral drugs available for these human coronavirus infections. Intensive research on the novel emerging human infectious coronaviruses is urgently needed to elucidate their route of transmission and pathogenic mechanisms, and to identify potential drug targets, which would promote the development of effective preventive and therapeutic countermeasures. Herein, we describe the epidemic and etiological characteristics of 2019-nCoV, discuss its essential biological features, including tropism and receptor usage, summarize approaches for disease prevention and treatment, and speculate on the transmission route of 2019-nCoV."],"journal":"Microbes Infect","authors":["Li, Jin-Yan","You, Zhi","Wang, Qiong","Zhou, Zhi-Jian","Qiu, Ye","Luo, Rui","Ge, Xing-Yi"],"date":"2020-02-23T11:00:00Z","year":2020,"_id":"32087334","week":"20208|Feb 17 - Feb 23","doi":"10.1016/j.micinf.2020.02.002","keywords":["*2019-nCoV","*ACE2","*Bat","*Pneumonia","*SARS-CoV","*Spike"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment"],"weight":1,"_version_":1663352134535479296,"score":44.120758},{"pmid":32278795,"title":"Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease.","text":["Creating Dermatology Guidelines for Covid-19: The Pitfalls of Applying Evidence Based Medicine to an Emerging Infectious Disease.","J Am Acad Dermatol","Freeman, Esther E","McMahon, Devon E","32278795"],"journal":"J Am Acad Dermatol","authors":["Freeman, Esther E","McMahon, Devon E"],"date":"2020-04-13T11:00:00Z","year":2020,"_id":"32278795","week":"202016|Apr 13 - Apr 19","doi":"10.1016/j.jaad.2020.04.002","keywords":["COVID-19","dermatology","evidence-based medicine","medical ethics","practice guidelines","quality assurance"],"source":"PubMed","topics":["Prevention"],"weight":1,"_version_":1663890922029449216,"score":42.867992}]}